Dividend
-
-
-
-
-
-
-
Bristol-Myers Squibb Shareholders Approve Celgene Acquisition
-
-
-
-
-
-
-
Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Mate
-
-
-
-
-
-
-
Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with Proposed Merger with Celgene
-
-
-
-
-
-
-
Drugmaker Shire soars as Japan's Takeda considers bid
-
-
-
-
-
-
-
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
-
-
-
-
-
378,501 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All